Relmada Therapeutics (RLMD) Cash from Financing Activities (2012 - 2026)
Relmada Therapeutics (RLMD) reported Cash from Financing Activities of -$6.42 million for Q2 2026.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Relmada Therapeutics' Cash from Financing Activities came in at $243.79 million; for FY2025, it came in at $93.56 million.
- Cash from Financing Activities has a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at -$40,341 in FY2024, -$98,463 in FY2023, $45.02 million in FY2022 (-76.0%) and $187.94 million in FY2021 (+560.1%).
- The Q2 2026 figure ranks as the lowest quarterly Cash from Financing Activities in data going back to Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Relmada Therapeutics | 402.15 Mn | 402.15 Mn | - | -6.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.42 Mn |
| Mar 31, 2026 | 156.57 Mn |
| Dec 31, 2025 | 93.64 Mn |
| Dec 31, 2024 | -172,487.00 |
| Sep 30, 2024 | -89,601.00 |
| Mar 31, 2024 | 221,747.00 |
| Dec 31, 2022 | 409,883.00 |
| Sep 30, 2022 | 569,092.00 |
| Jun 30, 2022 | 14.09 Mn |
| Mar 31, 2022 | 29.95 Mn |
| Dec 31, 2021 | 161.84 Mn |
| Sep 30, 2021 | 185,156.00 |
| Jun 30, 2021 | 23.99 Mn |
| Mar 31, 2021 | 1.93 Mn |
| Dec 31, 2020 | 944,153.00 |
| Sep 30, 2020 | 1.63 Mn |
| Jun 30, 2020 | 22.89 Mn |
| Mar 31, 2020 | 3.00 Mn |
| Dec 31, 2019 | 106.99 Mn |
| Sep 30, 2019 | 1.17 Mn |
API Access
Relmada Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();